News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Sean Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Smith Sean Michael (Interim CFO, Prin Acct Off) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Sold 1,323 shares
@ $0.6184, valued at
$818.1
Exercised 5,000 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Smith Sean Michael (Principal Accounting Officer) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Sold 1,655 shares
@ $0.9914, valued at
$1.6k
Exercised 5,000 restricted stock units
@ $0 |
|
| 08/04/2022 |
4
| Smith Sean Michael (Principal Accounting Officer) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.99, valued at
$148.5k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|